Jonathan C. Javitt - 07 Dec 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Issuer symbol
NRXP
Transactions as of
07 Dec 2022
Net transactions value
-$400,000
Form type
4
Filing time
09 Dec 2022, 15:33:05 UTC
Previous filing
02 Jun 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Sale $400,000 -400,000 -3% $1.00 12,899,997 07 Dec 2022 By Trust F1, F2
holding NRXP Common Stock, par value $0.001 per share 1,422,000 07 Dec 2022 By Trust F3
holding NRXP Common Stock, par value $0.001 per share 146,332 07 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Private sale pursuant to an option granted by the Reporting Person in 2017 in support of a financing for NeuroRx, Inc. Purchaser has agreed to hold the shares for a period of one year.
F2 Held by the Jonathan Javitt Living Trust. The Reporting Person is a trustee of the Trust.
F3 Held by the Javitt 2012 Irrevocable Dynasty Trust. The Reporting Person is the grantor of the Trust.